Search results

Search:
in the keywords: drug

Sort By:

Limit search:

THE STUDY OF ADSORPTION AND DESORPTION OF ANTIBIOTICS ON THE SURFACE OF NANOPARTICLES

100%

Biernat P., Borak B., Meler J., Karolewicz B.

Acta Poloniae Pharmaceutica - Drug Research

2018

vol. 75

issue 5

1215-1222

Nanotechnology is a field that is gaining more and more importance in the modern world. It uses a particle size of between a few dozen to a few hundred nanometers, or 10-9 meters. It is noted that the use of nanospheres (balls with a diameter of from several to several hundred nm) as carriers of drugs gives an opportunity for their controlled and sustained release. (1,2) Nanospheres as a potential drug carrier for sustained release may enhance the effectiveness of antibiotics. In order to examine the effects of antibiotics with nanospheres an attempt was made to deposit on them three drugs differing in chemical structure. These were chloramphenicol, gentamicin and ceftazidime. The aim of this study was to determine the degree of adsorption of the drug on the surface of nanospheres and to examine the process of desorption from the surface of silica nanoparticles. The results of the study indicate that in the case of chloramphenicol it is essentially a process of chemisorption, and for gentamicin and ceftazidime both physical and chemical adsorption, without there being any clearly defined relationship between this two processes. The purpose of the nanospheres as drug carriers is to obtain controlled and prolonged exposure to the drug. The amount of adsorbed substance depends primarily on its structure. Ceftazidime, as the compound with the highest number of double bonds, and a large number of groups to form hydrogen bonds (carbonyl groups, amino groups), adsorbed to the greatest extent.

Nowe celowane leki małocząsteczkowe w leczeniu astmy

84%

Romantowski J., Niedoszytko M. N.

Alergia Astma Immunologia - przegląd kliniczny

2019

vol. 24

issue 3

131-136

Asthma is a common chronic bronchial disease that is a major social problem in the world. Despite significant advances in inhalation therapy in recent decades, severe asthma remains a challenge for modern medicine. The heterogeneity of the mechanisms behind the severity of symptoms and resistance to classic inhalation drugs significantly impedes the search for targeted drugs in a group of patients with no satisfactory disease control based on basic drugs. To date, research on new drugs in severe asthma has mainly focused on antibody synthesis. However, a relatively large molecule of these drugs imposes some restrictions on the way of their administration and diagostic targets. The article discusses new therapeutic options associated with low molecular weight drugs under 900 Dalton being developed in recent years

Astma jest częstą chorobą przewlekła oskrzeli, stanowiącą istotny problem społeczny na świecie. Pomimo znacznego postępu w terapii wziewnej w ostatnich dekadach, astma ciężka stanowi nadal wyzwanie dla współczesnej medycyny. Heterogenność mechanizmów stojących za nasileniem objawów i oporność na klasyczne leki wziewne znacznie utrudnia poszukiwanie celowanych leków w grupie chorych nie uzyskujących zadowalającej kontroli choroby w oparciu o podstawowe leki. Dotychczasowe badania nad nowymi lekami w ciężkiej astmie koncentrują się głównie na syntezie przeciwciał. Jednak relatywnie duża cząsteczka tych leków nakłada na nie pewne ograniczenia związane z drogą podania i możliwymi punktami uchwytu. Niniejszy artykuł omawia nowe możliwości terapeutyczne związane z opracowywanymi w ostatnich latach lekami małocząsteczkowymi o masie poniżej 900 Daltonów.

Refine search results

1 Acta Poloniae Pharmaceutica - Drug Research

1 Alergia Astma Immunologia - przegląd kliniczny

1 2019

1 2018

1 Biernat P.

1 Borak B.

1 Karolewicz B.

1 Meler J.

1 Niedoszytko M. N.

1 Romantowski J.

Search results

THE STUDY OF ADSORPTION AND DESORPTION OF ANTIBIOTICS ON THE SURFACE OF NANOPARTICLES

Nowe celowane leki małocząsteczkowe w leczeniu astmy